These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 10518305)

  • 21. Multiple oncogenes and tumor suppressor genes are structurally and functionally intact during hepatocarcinogenesis in hepatitis B virus transgenic mice.
    Pasquinelli C; Bhavani K; Chisari FV
    Cancer Res; 1992 May; 52(10):2823-9. PubMed ID: 1316229
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Geographic characterization of hepatitis virus infections, genotyping of hepatitis B virus, and p53 mutation in hepatocellular carcinoma analyzed by in situ detection of viral genomes from carcinoma tissues: comparison among six different countries.
    Ding X; Park YN; Taltavull TC; Thung SN; Jin X; Jin Y; Trung NS; Edamoto Y; Sata T; Abe K
    Jpn J Infect Dis; 2003 Feb; 56(1):12-8. PubMed ID: 12711820
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical and pathological factors associated with the development of hepatocellular carcinoma in patients with hepatitis virus-related cirrhosis: a long-term follow-up study.
    Rodríguez-Díaz JL; Rosas-Camargo V; Vega-Vega O; Morales-Espinosa D; Mendez-Reguera A; Martínez-Tlahuel JL; Gamboa-Domínguez A; Arrieta O
    Clin Oncol (R Coll Radiol); 2007 Apr; 19(3):197-203. PubMed ID: 17359907
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of hepatitis B virus genotype mixture, subgenotypes C2 and B2 on hepatocellular carcinoma: compared with chronic hepatitis B and asymptomatic carrier state in the same area.
    Yin J; Zhang H; Li C; Gao C; He Y; Zhai Y; Zhang P; Xu L; Tan X; Chen J; Cheng S; Schaefer S; Cao G
    Carcinogenesis; 2008 Sep; 29(9):1685-91. PubMed ID: 18192693
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Clinical and molecular correlation between chronic hepatitis and hepatocellular carcinoma induced by hepatitis B virus].
    Shapiro IIa; Shabrov AV; Karev VE; Leenman EE; Kvetnoĭ IM; Tsinzerling VA; Sologub TV
    Arkh Patol; 2005; 67(2):6-10. PubMed ID: 15938110
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Allelic loss of chromosome 4q21 approximately 23 associates with hepatitis B virus-related hepatocarcinogenesis and elevated alpha-fetoprotein.
    Yeh SH; Lin MW; Lu SF; Wu DC; Tsai SF; Tsai CY; Lai MY; Hsu HC; Chen DS; Chen PJ
    Hepatology; 2004 Oct; 40(4):847-54. PubMed ID: 15382172
    [TBL] [Abstract][Full Text] [Related]  

  • 27. T1653 mutation in the box alpha increases the risk of hepatocellular carcinoma in patients with chronic hepatitis B virus genotype C infection.
    Ito K; Tanaka Y; Orito E; Sugiyama M; Fujiwara K; Sugauchi F; Kato T; Tokita H; Izumi N; Kato M; Yuen MF; Lai CL; Gish RG; Ueda R; Mizokami M
    Clin Infect Dis; 2006 Jan; 42(1):1-7. PubMed ID: 16323084
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preneoplastic markers of hepatitis B virus-associated hepatocellular carcinoma.
    Hann HW; Lee J; Bussard A; Liu C; Jin YR; Guha K; Clayton MM; Ardlie K; Pellini MJ; Feitelson MA
    Cancer Res; 2004 Oct; 64(20):7329-35. PubMed ID: 15492253
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hepatitis B virus-associated multistep hepatocarcinogenesis: a stepwise increase in allelic alterations.
    Lee JM; Wong CM; Ng IO
    Cancer Res; 2008 Jul; 68(14):5988-96. PubMed ID: 18632655
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association of HLA-DRB1*13 and TNF-alpha gene polymorphisms with clearance of chronic hepatitis B infection and risk of hepatocellular carcinoma in Thai population.
    Kummee P; Tangkijvanich P; Poovorawan Y; Hirankarn N
    J Viral Hepat; 2007 Dec; 14(12):841-8. PubMed ID: 18070287
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association of cytokine and DNA repair gene polymorphisms with hepatitis B-related hepatocellular carcinoma.
    Chen CC; Yang SY; Liu CJ; Lin CL; Liaw YF; Lin SM; Lee SD; Chen PJ; Chen CJ; Yu MW
    Int J Epidemiol; 2005 Dec; 34(6):1310-8. PubMed ID: 16172101
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hepatocarcinogenesis: hepatitis viruses and altered tumor suppressor gene function.
    Tabor E
    Princess Takamatsu Symp; 1995; 25():151-61. PubMed ID: 8875620
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genetics of hepatocellular carcinoma.
    Buendia MA
    Semin Cancer Biol; 2000 Jun; 10(3):185-200. PubMed ID: 10936068
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comprehensive allelotype study of hepatocellular carcinoma: potential differences in pathways to hepatocellular carcinoma between hepatitis B virus-positive and -negative tumors.
    Okabe H; Ikai I; Matsuo K; Satoh S; Momoi H; Kamikawa T; Katsura N; Nishitai R; Takeyama O; Fukumoto M; Yamaoka Y
    Hepatology; 2000 May; 31(5):1073-9. PubMed ID: 10796882
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hepatocellular carcinoma: New and emerging risks.
    Sherman M
    Dig Liver Dis; 2010 Jul; 42 Suppl 3():S215-22. PubMed ID: 20547306
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression profile of nine novel genes differentially expressed in hepatitis B virus-associated hepatocellular carcinomas.
    Kim MY; Park E; Park JH; Park DH; Moon WS; Cho BH; Shin HS; Kim DG
    Oncogene; 2001 Jul; 20(33):4568-75. PubMed ID: 11494152
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Large-scale analysis of the genetic and epigenetic alterations in hepatocellular carcinoma from Southeast China.
    Su H; Zhao J; Xiong Y; Xu T; Zhou F; Yuan Y; Zhang Y; Zhuang SM
    Mutat Res; 2008 May; 641(1-2):27-35. PubMed ID: 18358501
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Virological and clinical implication of core promoter C1752/V1753 and T1764/G1766 mutations in hepatitis B virus genotype D infection in Mongolia.
    Elkady A; Tanaka Y; Kurbanov F; Oynsuren T; Mizokami M
    J Gastroenterol Hepatol; 2008 Mar; 23(3):474-81. PubMed ID: 18318825
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mechanisms of HBV-related hepatocarcinogenesis.
    Neuveut C; Wei Y; Buendia MA
    J Hepatol; 2010 Apr; 52(4):594-604. PubMed ID: 20185200
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevention and surveillance of hepatitis B virus-related hepatocellular carcinoma.
    Liaw YF
    Semin Liver Dis; 2005; 25 Suppl 1():40-7. PubMed ID: 16103980
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.